nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Hypothyroidism—Vandetanib—thyroid cancer	0.0618	0.0618	CcSEcCtD
Ethionamide—Hypothyroidism—Sorafenib—thyroid cancer	0.0417	0.0417	CcSEcCtD
Ethionamide—Hypoglycaemia—Vandetanib—thyroid cancer	0.0295	0.0295	CcSEcCtD
Ethionamide—Neurotoxicity—Epirubicin—thyroid cancer	0.0255	0.0255	CcSEcCtD
Ethionamide—Gynaecomastia—Sorafenib—thyroid cancer	0.0239	0.0239	CcSEcCtD
Ethionamide—Neurotoxicity—Doxorubicin—thyroid cancer	0.0236	0.0236	CcSEcCtD
Ethionamide—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0227	0.0227	CcSEcCtD
Ethionamide—Weight decreased—Vandetanib—thyroid cancer	0.0225	0.0225	CcSEcCtD
Ethionamide—Depression—Vandetanib—thyroid cancer	0.0221	0.0221	CcSEcCtD
Ethionamide—Stomatitis—Vandetanib—thyroid cancer	0.0216	0.0216	CcSEcCtD
Ethionamide—Dysgeusia—Vandetanib—thyroid cancer	0.017	0.017	CcSEcCtD
Ethionamide—Vision blurred—Vandetanib—thyroid cancer	0.0163	0.0163	CcSEcCtD
Ethionamide—Optic neuritis—Epirubicin—thyroid cancer	0.0161	0.0161	CcSEcCtD
Ethionamide—Erectile dysfunction—Sorafenib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Ethionamide—Weight decreased—Sorafenib—thyroid cancer	0.0152	0.0152	CcSEcCtD
Ethionamide—Optic neuritis—Doxorubicin—thyroid cancer	0.0149	0.0149	CcSEcCtD
Ethionamide—Neuropathy peripheral—Sorafenib—thyroid cancer	0.0147	0.0147	CcSEcCtD
Ethionamide—Jaundice—Sorafenib—thyroid cancer	0.0146	0.0146	CcSEcCtD
Ethionamide—Stomatitis—Sorafenib—thyroid cancer	0.0146	0.0146	CcSEcCtD
Ethionamide—Thrombocytopenia—Vandetanib—thyroid cancer	0.0139	0.0139	CcSEcCtD
Ethionamide—Neuritis—Epirubicin—thyroid cancer	0.0132	0.0132	CcSEcCtD
Ethionamide—Dyspepsia—Vandetanib—thyroid cancer	0.0125	0.0125	CcSEcCtD
Ethionamide—Decreased appetite—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Ethionamide—Neuritis—Doxorubicin—thyroid cancer	0.0123	0.0123	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0122	0.0122	CcSEcCtD
Ethionamide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Ethionamide—Dysgeusia—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Ethionamide—Abdominal pain—Vandetanib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Ethionamide—Diarrhoea—Vandetanib—thyroid cancer	0.00968	0.00968	CcSEcCtD
Ethionamide—Salivary hypersecretion—Epirubicin—thyroid cancer	0.0096	0.0096	CcSEcCtD
Ethionamide—Dizziness—Vandetanib—thyroid cancer	0.00935	0.00935	CcSEcCtD
Ethionamide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00934	0.00934	CcSEcCtD
Ethionamide—Anorexia—Sorafenib—thyroid cancer	0.0091	0.0091	CcSEcCtD
Ethionamide—Vomiting—Vandetanib—thyroid cancer	0.00899	0.00899	CcSEcCtD
Ethionamide—Rash—Vandetanib—thyroid cancer	0.00892	0.00892	CcSEcCtD
Ethionamide—Dermatitis—Vandetanib—thyroid cancer	0.00891	0.00891	CcSEcCtD
Ethionamide—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00888	0.00888	CcSEcCtD
Ethionamide—Headache—Vandetanib—thyroid cancer	0.00886	0.00886	CcSEcCtD
Ethionamide—Nausea—Vandetanib—thyroid cancer	0.0084	0.0084	CcSEcCtD
Ethionamide—Dyspepsia—Sorafenib—thyroid cancer	0.0084	0.0084	CcSEcCtD
Ethionamide—Decreased appetite—Sorafenib—thyroid cancer	0.0083	0.0083	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00824	0.00824	CcSEcCtD
Ethionamide—Photosensitivity—Epirubicin—thyroid cancer	0.00817	0.00817	CcSEcCtD
Ethionamide—Vascular purpura—Epirubicin—thyroid cancer	0.00802	0.00802	CcSEcCtD
Ethionamide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.0078	0.0078	CcSEcCtD
Ethionamide—Photosensitivity—Doxorubicin—thyroid cancer	0.00756	0.00756	CcSEcCtD
Ethionamide—Abdominal pain—Sorafenib—thyroid cancer	0.00754	0.00754	CcSEcCtD
Ethionamide—Purpura—Epirubicin—thyroid cancer	0.00744	0.00744	CcSEcCtD
Ethionamide—Vascular purpura—Doxorubicin—thyroid cancer	0.00742	0.00742	CcSEcCtD
Ethionamide—Hypoglycaemia—Epirubicin—thyroid cancer	0.00735	0.00735	CcSEcCtD
Ethionamide—Diplopia—Epirubicin—thyroid cancer	0.00718	0.00718	CcSEcCtD
Ethionamide—Hypersensitivity—Sorafenib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Ethionamide—Purpura—Doxorubicin—thyroid cancer	0.00689	0.00689	CcSEcCtD
Ethionamide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.0068	0.0068	CcSEcCtD
Ethionamide—Diplopia—Doxorubicin—thyroid cancer	0.00664	0.00664	CcSEcCtD
Ethionamide—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00655	0.00655	CcSEcCtD
Ethionamide—Diarrhoea—Sorafenib—thyroid cancer	0.00653	0.00653	CcSEcCtD
Ethionamide—Dizziness—Sorafenib—thyroid cancer	0.00631	0.00631	CcSEcCtD
Ethionamide—Vomiting—Sorafenib—thyroid cancer	0.00607	0.00607	CcSEcCtD
Ethionamide—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00606	0.00606	CcSEcCtD
Ethionamide—Rash—Sorafenib—thyroid cancer	0.00602	0.00602	CcSEcCtD
Ethionamide—Dermatitis—Sorafenib—thyroid cancer	0.00601	0.00601	CcSEcCtD
Ethionamide—Headache—Sorafenib—thyroid cancer	0.00598	0.00598	CcSEcCtD
Ethionamide—Nausea—Sorafenib—thyroid cancer	0.00567	0.00567	CcSEcCtD
Ethionamide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00566	0.00566	CcSEcCtD
Ethionamide—Weight decreased—Epirubicin—thyroid cancer	0.00561	0.00561	CcSEcCtD
Ethionamide—Drowsiness—Epirubicin—thyroid cancer	0.00553	0.00553	CcSEcCtD
Ethionamide—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00542	0.00542	CcSEcCtD
Ethionamide—Stomatitis—Epirubicin—thyroid cancer	0.00539	0.00539	CcSEcCtD
Ethionamide—Jaundice—Epirubicin—thyroid cancer	0.00539	0.00539	CcSEcCtD
Ethionamide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00524	0.00524	CcSEcCtD
Ethionamide—Weight decreased—Doxorubicin—thyroid cancer	0.00519	0.00519	CcSEcCtD
Ethionamide—Drowsiness—Doxorubicin—thyroid cancer	0.00512	0.00512	CcSEcCtD
Ethionamide—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00502	0.00502	CcSEcCtD
Ethionamide—Jaundice—Doxorubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Ethionamide—Stomatitis—Doxorubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Ethionamide—Hepatitis—Epirubicin—thyroid cancer	0.00496	0.00496	CcSEcCtD
Ethionamide—Hepatitis—Doxorubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Ethionamide—Dysgeusia—Epirubicin—thyroid cancer	0.00423	0.00423	CcSEcCtD
Ethionamide—Vision blurred—Epirubicin—thyroid cancer	0.00407	0.00407	CcSEcCtD
Ethionamide—Agitation—Epirubicin—thyroid cancer	0.00397	0.00397	CcSEcCtD
Ethionamide—Dysgeusia—Doxorubicin—thyroid cancer	0.00392	0.00392	CcSEcCtD
Ethionamide—Vision blurred—Doxorubicin—thyroid cancer	0.00377	0.00377	CcSEcCtD
Ethionamide—Agitation—Doxorubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Ethionamide—Thrombocytopenia—Epirubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Ethionamide—Anorexia—Epirubicin—thyroid cancer	0.00336	0.00336	CcSEcCtD
Ethionamide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Ethionamide—Somnolence—Epirubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Ethionamide—Anorexia—Doxorubicin—thyroid cancer	0.00311	0.00311	CcSEcCtD
Ethionamide—Dyspepsia—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Ethionamide—Decreased appetite—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00304	0.00304	CcSEcCtD
Ethionamide—Somnolence—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Ethionamide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Ethionamide—Dyspepsia—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Ethionamide—Decreased appetite—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00282	0.00282	CcSEcCtD
Ethionamide—Abdominal pain—Epirubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Ethionamide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Ethionamide—Hypersensitivity—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Ethionamide—Abdominal pain—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Ethionamide—Diarrhoea—Epirubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Ethionamide—Hypersensitivity—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Ethionamide—Dizziness—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Ethionamide—Vomiting—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Ethionamide—Diarrhoea—Doxorubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Ethionamide—Rash—Epirubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Ethionamide—Dermatitis—Epirubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Ethionamide—Headache—Epirubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Ethionamide—Dizziness—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Ethionamide—Nausea—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Ethionamide—Vomiting—Doxorubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Ethionamide—Rash—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Ethionamide—Dermatitis—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Ethionamide—Headache—Doxorubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Ethionamide—Nausea—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
